{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-311305","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.687687+00:00","generated_at":"2026-05-16T13:57:47.567014+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"confidence":"high","headline":"Clearside Biomedical files Form 25 to complete Nasdaq delisting after Chapter 11 bankruptcy","bullets":["Filed Form 25 on Dec 8, 2025 to delist from Nasdaq and deregister under Section 12(b); effective no earlier than Dec 18, 2025.","Nasdaq delisting notice received Nov 24, 2025 after Chapter 11 filing (Case No. 25-12109); trading suspended Dec 1, 2025.","Common stock trades on OTC Pink under symbol CLSDQ since Dec 1, 2025.","Deregistration will reduce SEC reporting obligations 90 days after Form 25 effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-311305","json":"https://secwatch.observer/filing/0001193125-25-311305.json","markdown":"https://secwatch.observer/filing/0001193125-25-311305.md","text":"https://secwatch.observer/filing/0001193125-25-311305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525311305/0001193125-25-311305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525311305/d98628d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:57:47.567014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}